Yu-Cheng Chen

Access to What

K. Liao, Chang-Jer Wu, Shih-Han Kao, 1998 .

A fusion protein composed of receptor binding domain of vascular endothelial growth factor-A and constant region fragment of antibody: angiogenesis antagonistic activity

R. Pan, Chia-Hung Chen, Yen-Ku Liu, 2011, Cytotechnology.

The treatment of propofol induced the TGF-β1 expression in human endothelial cells to suppress endocytosis activities of monocytes.

Yu-Ling Lin, K. Liao, C. Li, 2010, Cytokine.

Enhancement of anti-murine colon cancer immunity by fusion of a SARS fragment to a low-immunogenic carcinoembryonic antigen

K. Liao, Chang-Jer Wu, Shih-Han Kao, 2012, Biological Procedures Online.

A fusion protein with the receptor-binding domain of vascular endothelial growth factor-A (VEGF-A) is an antagonist of angiogenesis in cancer treatment: Simultaneous blocking of VEGF receptor-1 and 2

Y. Lai, Chia-Hung Chen, Yen-Ku Liu, 2010, Cancer biology & therapy.